AAAAAA

   
Results: 1-3 |
Results: 3
Treatment with gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial (vol 15, pg 1490, 2000)
Authors: Borm, G Mannaerts, B
Citation: G. Borm et B. Mannaerts, Treatment with gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial (vol 15, pg 1490, 2000), HUM REPR, 15(8), 2000, pp. 1877-1877
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix inwomen undergoing ovarian stimulation with recombinant follicle stimulatinghormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial
Authors: Borm, G Mannaerts, B
Citation: G. Borm et B. Mannaerts, Treatment with the gonadotrophin-releasing hormone antagonist ganirelix inwomen undergoing ovarian stimulation with recombinant follicle stimulatinghormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial, HUM REPR, 15(7), 2000, pp. 1490-1498
Does intracytoplasmic sperm injection lead to a rise in the frequency of microdeletions in the AZFc region of the Y chromosome in future generations?
Authors: Kremer, JAM Tuerlings, JHAM Borm, G Hoefsloot, LH Meuleman, EJH Braat, DDM Brunner, HG Merkus, HMWM
Citation: Jam. Kremer et al., Does intracytoplasmic sperm injection lead to a rise in the frequency of microdeletions in the AZFc region of the Y chromosome in future generations?, HUM REPR, 13(10), 1998, pp. 2808-2811
Risultati: 1-3 |